Abemaciclib with endocrine therapy in the treatment of high-risk early breast cancer: ASCO Optimal Adjuvant Chemotherapy and Targeted Therapy Guideline rapid recommendation update - Giordano, S H; Freedman, R A; Somerfield, M R (J Clin Oncol, 2022)